RecruitingNCT06781697
Intravenous ketamine with virtual reality for difficult-to-treat depression
About this title
Read the official source — NCT06781697Medication studyAges 18+Canada
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 3, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 31
- Sponsor
- Sunnybrook Health Sciences Centre
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT06781697
- Official title
Show the full official title
InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression (TREASURE Trial): a Pilot, Randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sunnybrook Health Sciences Centre.
Does this study involve medication?
Yes. The study involves medication, including ketamine.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
